Open Gene · Flagship Report

State of Gene Editing in Mexico 2026

A national assessment of the people, institutions, infrastructure, research, regulation and translation shaping Mexico's gene-editing ecosystem.

Working thesis

Mexico has scientific gene-editing capability, but not yet a cohesive national gene-editing ecosystem.

The 2026 report is being built to distinguish scientific capacity from ecosystem maturity: who can perform the work, where the infrastructure exists, how projects move toward translation, and which gaps still prevent isolated capabilities from becoming a connected national platform.

01 · National landscape

Measuring the ecosystem before describing it.

Final counts will be published only after source verification. Until then, the public page shows the dimensions being measured rather than invented headline numbers.

—

Researchers mapped

Verification in progress

—

Institutions & laboratories

Verification in progress

—

Active gene-editing projects

Verification in progress

—

Infrastructure nodes

Verification in progress

—

Clinical translation signals

Verification in progress

—

Companies & translational actors

Verification in progress

02 · What we are mapping

From individual researchers to national capability.

The report connects the Open Gene Mexico Index with infrastructure, projects, policy and translation to build a reproducible picture of the field.

People

Researchers and teams actively contributing to gene editing and directly enabling fields.

Institutions

Universities, research centers, hospitals, national laboratories and specialized units.

Infrastructure

CRISPR facilities, sequencing, cell culture, animal models, transformation, biobanks and enabling platforms.

Research

Projects across agriculture, human health, biotechnology, basic science and emerging editing technologies.

Translation

Patents, licensing, clinical research, technology transfer, startups and commercial development.

Policy

Regulation, biosecurity, research governance and the policy environment affecting gene-editing development.

03 · 2026 report structure

The questions the report will answer.

Executive Summary

Where Mexico stands in 2026 and the most important findings.

Defining Gene Editing

CRISPR, base editing, prime editing, TALEN, ZFN and adjacent technologies.

National Research Landscape

Institutions, laboratories, projects and geographic concentration.

People & Scientific Talent

Connected to the Open Gene Mexico Index.

Infrastructure

Experimental and enabling capabilities available in Mexico.

Agriculture & Plant Editing

Research, applications, transformation capacity and translational potential.

Human Health & Therapeutic Editing

Discovery, preclinical work, clinical signals and translation gaps.

Regulation & Biosecurity

The rules, agencies and unresolved questions shaping the field.

Industry, Funding & Technology Transfer

Companies, capital, grants, licensing and routes from laboratory to application.

Mexico 2030

The capabilities and coordination required to become a relevant gene-editing hub.

04 · Methodology

Built to be useful, verifiable and repeatable.

Entries are not included merely because they are adjacent to genomics or biotechnology. The report distinguishes direct gene-editing activity from enabling capabilities and broader genetic research. Public claims are intended to be traceable to institutional, regulatory, trial, publication or researcher-provided sources.

01
Identify researchers, institutions, projects and infrastructure.
02
Classify direct gene-editing activity versus enabling fields.
03
Verify each material claim against source documentation.
04
Invite researchers and institutions to correct or expand their records.
05
Publish methodology, limitations and future revisions transparently.

Contribute to the 2026 edition

Are we missing your laboratory, project or institution?

Open Gene is collecting source-backed information from researchers, institutions and organizations across Mexico. Submissions are reviewed before inclusion.